Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-3-6
pubmed:abstractText
The aetiology of idiopathic bronchiectasis, a lung disease where chronic inflammation and bacterial infection leads to progressive lung damage, is unknown. A possible role for natural killer cells has been highlighted previously. However, a role for adaptive immunity is suggested by the presence of CD4 and CD8 T cells in diseased lung tissue. Evidence of a human leucocyte antigen (HLA) class II disease association would further implicate a role for adaptive immunity. To establish if there is any HLA association, we analysed HLA-A, HLA-B, HLA-DQA1, HLA-DQB1 and HLA-DRB1 alleles in patients with idiopathic bronchiectasis and controls. Genomic DNA from 92 adults with idiopathic bronchiectasis and 101 healthy controls was analysed by polymerase chain reaction with sequence-specific primers. We found an increase in the prevalence of HLA-DRB1*01 DQA1*01/DQB1*05 genes in idiopathic bronchiectasis; that is, the HLA-DR1, DQ5 haplotype (odds ratio 2.19, 95% confidence interval 1.15-4.16, P = 0.0152) compared with control subjects. The association with HLA-DR1, DQ5 implicates a role for CD4 T cells restricted by these molecules in susceptibility to the progressive lung damage seen in this disease. This may operate either through influencing susceptibility to specific pathogens or to self-reactivity and requires further investigation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-10228112, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-10531174, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-10700238, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-10764335, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-10931128, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-11029331, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-11120838, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-11120841, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-11719301, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-1299350, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-14688318, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-15358724, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-15383555, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-1567812, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-15809348, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-16254274, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-16824023, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-17026468, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-17436225, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-17496894, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-17521317, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-1910448, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-2059078, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-2678579, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-7734418, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-8622334, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-9243750, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-9331945, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-9828857, http://linkedlifedata.com/resource/pubmed/commentcorrection/18241227-9927368
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1365-2249
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
152
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
95-101
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity.
pubmed:affiliation
Lung Immunology Group, NHLI, Sir Alexander Fleming Building, South Kensington Campus, Faculty of Medicine, Imperial College, London, UK. r.boyton@imperial.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't